secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABEONA THERAPEUTICS INC. (ABEO)
CIK:        0000318306
Form:       8-K
Filed at:   2024-05-03T23:59:59+00:00
Accession:  0001493152-24-017625
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Abeona reports preliminary Q1 cash $62.7M; terminates $106M ATM prospectus
--------------------------------------------------------------------------

- Preliminary cash, equivalents, and investments of $62.7M as of March 31, 2024.
- Terminated June 2023 ATM prospectus covering up to $106M in common shares.
- No sales under Sales Agreement until a new prospectus or registration statement is filed.
- Sales Agreement itself remains in effect; only the specific supplement is suspended.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318306/000149315224017625/0001493152-24-017625-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318306/000149315224017625/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-017625

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer